Introducing, Selma Blair Documentary Discussion Guide Now Available

We invite the MS community to watch Selma Blair’s award-winning documentary Introducing, Selma Blair now available for streaming on Discovery+. In the film, Ms. Blair shares her experiences and challenges with multiple sclerosis and provides an inside view of her journey of personal acceptance and resilience after being diagnosed with MS.  Viewers are also encouraged to access […]

Read News Article

What’s New in MS Research – November 2021

Reviewed by MSAA Chief Medical Officer Barry A. Hendin, MD In this Article More evidence on the benefits of starting DMTs sooner rather than later Assessing the impact of Ocrevus® on patients with early-stage relapsing-remitting MS Investigational agent ublituximab lowers relapse rate in two Phase III studies Study details tolebrutinib efficacy, safety profile over 48 […]

Read News Article

What’s New in MS Research – September 2021

Reviewed by MSAA Chief Medical Officer Barry A. Hendin, MD In this Article Encouraging results from Phase II study of tolebrutinib FDA authorizes stem cell trial focused on people with mild-to-moderate MS Long-term study shows sustained efficacy, consistent safety profile for Tecfidera® No short-term increase in relapse risk from Pfizer/BioNTech COVID vaccine, study finds Government […]

Read News Article

What’s New in MS Research – July 2021

Reviewed by MSAA Chief Medical Officer Barry A. Hendin, MD In this Article Good cause to watch for anxiety and depression in the first year after MS diagnosis The case for “starting strong” with an initial disease-modifying therapy Positive results for the investigational disease-modifying therapy ublituximab Measuring the long-term effects of relapses in MS Exploring […]

Read News Article

My MSAA Community – Recognizing Five Years of Support from the Multiple Sclerosis Association of America

The Multiple Sclerosis Association of America’s (MSAA) free online support forum, My MSAA Community, has been a continued source of support, encouragement, and hope for members of the multiple sclerosis (MS) community since its creation in 2016. Powered by HealthUnlocked, My MSAA Community offers people with multiple sclerosis, care partners, friends, and family members a […]

Read News Article

What’s New in MS Research – May 2021

Reviewed by MSAA Chief Medical Officer Barry A. Hendin, MD In this Article Do you and your neurologist attach the same importance to various DMT benefits and risks? Characteristics and clinical outcomes of underserved minority patients with multiple sclerosis MRI findings yield clues to likelihood of MS worsening in pediatric patients Young and stressed over […]

Read News Article

Join the Multiple Sclerosis Association of America for the First-Ever Virtual Improving Lives Benefit in Support of the MS Community

For six years, the Multiple Sclerosis Association of America (MSAA) has been honored to host our annual Improving Lives Benefit in-person, raising funds for the MS community. Now, MSAA is excited to bring our community “Together at Home” for our first-ever virtual Improving Lives Benefit, showcasing more than 50 years of hope, impact, and support […]

Read News Article

What’s New in MS Research: March 2021

The first quarter of 2021 has been marked by welcome news on the medical front, and those hopeful developments aren’t limited to the increasing number of COVID-19 vaccinations being given across the country. Significant strides in treating and understanding MS also have been made in these early months of the year, as detailed in this edition of “What’s New in MS Research.”

Read News Article

FDA Approves Ponvory for the Treatment of Relapsing Forms of MS

Updated: March 25, 2021 to include patient assistance resource information Reviewed by MSAA Chief Medical Officer Barry A. Hendin, MD The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the United States Food and Drug Administration (FDA) approved Ponvory™ (ponesimod) for the treatment of relapsing forms of multiple sclerosis (MS) in adults – including […]

Read News Article